"小林製薬社長「原因究明と再発防止が責任」、紅こうじ製品の問題で," 29 March 2024

[Japanese-to-English translation by Business & Human Rights Resource Centre]

Kobayashi Pharmaceutical ( 4967.T) President Kobayashi Akihiro held a press conference in Osaka on the 29th in regards to the issue of the growing health damage allegedly occurring among those who consume the company's products. He said that the top priority is to ensure that those who are complaining of health damage are examined and treated, and that it is important to provide compensation if necessary...

Kobayashi also said, "It is our responsibility to investigate the cause and take measures to prevent recurrence. As a leader, I would like to move forward with that at this time."

... Regarding the burden of product recall costs and other expenses, the company explained due to the impact spreading more than expected, "it is extremely difficult to calculate what the total amount will be."

...